Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence.

MLA

Morin, Aurélie, et al. “Identification of CAD as an Androgen Receptor Interactant and an Early Marker of Prostate Tumor Recurrence.” FASEB Journal, vol. 26, no. 1, Jan. 2012, pp. 460–67. EBSCOhost, https://doi.org/10.1096/fj.11-191296.

APA

Morin, A., Fritsch, L., Mathieu, J. R. R., Gilbert, C., Guarmit, B., Firlej, V., Gallou-Kabani, C., Vieillefond, A., Delongchamps, N. B., & Cabon, F. (2012). Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence. FASEB Journal, 26(1), 460–467. https://doi.org/10.1096/fj.11-191296

Chicago

Morin, Aurélie, Lauriane Fritsch, Jacques R. R. Mathieu, Cristèle Gilbert, Basma Guarmit, Virginie Firlej, Catherine Gallou-Kabani, Annick Vieillefond, Nicolas Barry Delongchamps, and Florence Cabon. 2012. “Identification of CAD as an Androgen Receptor Interactant and an Early Marker of Prostate Tumor Recurrence.” FASEB Journal 26 (1): 460–67. doi:10.1096/fj.11-191296.